Abstract
Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1198-1200 |
| Number of pages | 3 |
| Journal | Kidney international |
| Volume | 70 |
| Issue number | 7 |
| DOIs |
|
| State | Published - Oct 9 2006 |
ASJC Scopus subject areas
- Nephrology
Fingerprint Dive into the research topics of 'Treatment of the primary hyperoxalurias: A new chapter'. Together they form a unique fingerprint.
Cite this
Milliner, D. (2006). Treatment of the primary hyperoxalurias: A new chapter. Kidney international, 70(7), 1198-1200. https://doi.org/10.1038/sj.ki.5001821